Document is current
Any future updates will be listed below
-
Authors
Koletsa, Triantafyllia
Kotoula, Vassiliki
Koliou, Georgia-Angeliki
Manousou, Kyriaki
Chrisafi, Sofia
Zagouri, Flora
Sotiropoulou, Maria
Pentheroudakis, George
Papoudou-Bai, Alexandra
Christodoulou, Christos
Xepapadakis, Grigorios
Zografos, George
Petraki, Kalliopi
Pazarli, Elissavet
Koutras, Angelos
Kourea, Helen P.
Bafaloukos, Dimitrios
Chatzopoulos, Kyriakos
Iliadis, Alexandros
Markopoulos, Christos
Venizelos, Vasileios
Arnogiannaki, Niki
Kalogeras, Konstantine T.
Kostopoulos, Ioannis
Gogas, Helen
Fountzilas, George
-
Funding
Funding for this research was provided by:
Amgen Ltd.
Hellenic Cooperative Oncology Group (HE TRANS_BR)
- License Information
-
More Information
Article History
Received: 17 May 2019
Accepted: 28 March 2020
First Online: 18 April 2020
Compliance with ethical standards
:
: Pentheroudakis G: Advisory Role: Roche, Honoraria: Roche, Speaker bureau: Roche, Grants: Amgen; Christodoulou C: Advisory Role: Merck, Genesis Pharmaceuticals, Pfizer, Novartis, Roche, AstraZeneca, Bristol Myers Squibb. Honoraria: Roche, Bristol Myers Squibb. Travel: AstraZeneca, Sanofi; Koutras A: Advisory Role: Roche, Genesis, AstraZeneca. Travel: Novartis, Sanofi-Aventis, Astellas, Merck Serono, Bristol Myers Squibb, Pfizer, Genesis, Amgen. Gogas H: Advisory Role: Bristol-Myers Squibb, MSD Oncology, Amgen, Novartis, Roche, Pierre-Fabre, Honoraria: Bristol-Myers Squibb, MSD Oncology, Roche, Amgen, Novartis, Research Funding (institution): Bristol-Myers Squibb, Roche, MSD Oncology, Travel: Roche, Bristol-Myers Squibb; Fountzilas G: Advisory Board of Pfizer, Sanofi and Roche. Honoraria from Astra-Zeneca. The rest of the authors declare no conflict of interest.
: The present translational study was approved by the Bioethics Committee of the Aristotle University of Thessaloniki School of Medicine (#77/June 10, 2014) and by the Institutional Review Board of Papageorgiou Hospital of Thessaloniki (#725/May 10, 2013).
: Patients had signed a study-specific written informed consent before randomization, which in addition to giving consent for the trial allowed for the use of biological material for future research purposes.
